| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Minsoo Kim, Woonhee Kim, ChiHye Chun. The neural basis underlying female vulnerability to depressive disorders. Animal cells and systems. vol 27. issue 1. 2023-12-01. PMID:38023591. |
furthermore, other brain circuits involving the dopaminergic center (ventral tegmental area) and the serotonergic center (dorsal raphe nucleus), along with their respective projections, have shown sex differences in relation to depression. |
2023-11-29 |
2023-12-07 |
Not clear |
| Gabriel R Gilmore, Jeff Dych. Sleep/Wake Regularity and Cognition in College Students using Antidepressants. Physiology & behavior. 2023-11-22. PMID:37992793. |
the current project examined sleep, sleep/wake regularity, and cognition in college students diagnosed with depression and using serotonergic antidepressants and in those without a depression diagnosis. |
2023-11-22 |
2023-11-29 |
human |
| Emad H M Hassanein, Hanan S Althagafy, Mohammad A Baraka, Esraa K Abd-Alhameed, Islam M Ibrahi. Pharmacological update of mirtazapine: a narrative literature review. Naunyn-Schmiedeberg's archives of pharmacology. 2023-11-09. PMID:37943296. |
mtz is hypothesized to have antidepressant effects because of the synergy between noradrenergic and serotonergic actions and is effective in treating major depressive disorder and depression associated with epilepsy, alzheimer's disease, stroke, cardiovascular disease, and respiratory disease. |
2023-11-09 |
2023-11-20 |
Not clear |
| Adam Wojta. The possible place for psychedelics in pharmacotherapy of mental disorders. Pharmacological reports : PR. 2023-11-07. PMID:37934320. |
since its emergence in the 1960s, the serotonergic theory of depression bore fruit in the discovery of a plethora of antidepressant drugs affecting the lives of millions of patients. |
2023-11-07 |
2023-11-08 |
Not clear |
| Vera Flasbeck, Julia Hirsch, Frank Petrak, Juris J Meier, Stephan Herpertz, Sören Gatermann, Georg Jucke. Microbiome composition and central serotonergic activity in patients with depression and type 1 diabetes. European archives of psychiatry and clinical neuroscience. 2023-10-17. PMID:37847374. |
microbiome composition and central serotonergic activity in patients with depression and type 1 diabetes. |
2023-10-17 |
2023-11-08 |
human |
| Vera Flasbeck, Julia Hirsch, Frank Petrak, Juris J Meier, Stephan Herpertz, Sören Gatermann, Georg Jucke. Microbiome composition and central serotonergic activity in patients with depression and type 1 diabetes. European archives of psychiatry and clinical neuroscience. 2023-10-17. PMID:37847374. |
high α-diversity was associated with high ldaep, i.e., low serotonergic activity, in patients with diabetes and additional depression. |
2023-10-17 |
2023-11-08 |
human |
| Xin Wang, Feida Che, Xin Zhang, Ping Li, Wen Zhang, Bo Tan. Tracing Superoxide Anion in Serotonergic Neurons of Living Mouse Brains with Depression by Small-Molecule Fluorescence Probes. Analytical chemistry. 2023-10-13. PMID:37830753. |
tracing superoxide anion in serotonergic neurons of living mouse brains with depression by small-molecule fluorescence probes. |
2023-10-13 |
2023-10-15 |
mouse |
| Xin Wang, Feida Che, Xin Zhang, Ping Li, Wen Zhang, Bo Tan. Tracing Superoxide Anion in Serotonergic Neurons of Living Mouse Brains with Depression by Small-Molecule Fluorescence Probes. Analytical chemistry. 2023-10-13. PMID:37830753. |
the dysfunction of serotonergic neurons caused by oxidative stress in the brain is closely related to the occurrence and development of various mental diseases, such as depression. |
2023-10-13 |
2023-10-15 |
mouse |
| Kapil Kumar Goel, Somesh Thapliyal, Rajeev Kharb, Gaurav Joshi, Arvind Negi, Bhupinder Kuma. Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure-Activity Relationship Studies. Pharmaceutics. vol 15. issue 9. 2023-09-28. PMID:37765177. |
the focus of the study is to provide structural insights into imidazole-based derivatives as serotonergic system modulators for the treatment of depression. |
2023-09-28 |
2023-10-07 |
Not clear |
| Ofelia Limón-Morales, Kenia Morales-Quintero, Marcela Arteaga-Silva, Tania Molina-Jiménez, Marco Cerbón, Herlinda Bonilla-Jaim. Alterations of learning and memory are accompanied by alterations in the expression of 5-HT receptors, glucocorticoid receptor and brain-derived neurotrophic factor in different brain regions of an animal model of depression generated by neonatally male treatment with clomipramine in male rats. Behavioural brain research. 2023-09-15. PMID:37714467. |
in addition, depression is characterized by a decreased functioning of the serotonergic system due to changes in the activity or expression of its receptors including, most significantly, 5-ht1a, 5-ht2a, and 5-ht3 in brain regions that regulate mood, emotions, and memory, such as the prefrontal cortex, hippocampus, and amygdala. |
2023-09-15 |
2023-10-07 |
rat |
| Scotti McLaren, Karin Seidler, James Nei. Investigating the Role of 17β-Estradiol on the Serotonergic System, Targeting Soy Isoflavones as a Strategy to Reduce Menopausal Depression: A Mechanistic Review. Journal of the American Nutrition Association. 2023-09-11. PMID:37695875. |
investigating the role of 17β-estradiol on the serotonergic system, targeting soy isoflavones as a strategy to reduce menopausal depression: a mechanistic review. |
2023-09-11 |
2023-10-07 |
human |
| Ana Salomé Correia, Armando Cardoso, Nuno Val. BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions. Pharmaceutics. vol 15. issue 8. 2023-08-26. PMID:37631295. |
bdnf unveiled: exploring its role in major depression disorder serotonergic imbalance and associated stress conditions. |
2023-08-26 |
2023-09-07 |
human |
| Ana Salomé Correia, Armando Cardoso, Nuno Val. BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions. Pharmaceutics. vol 15. issue 8. 2023-08-26. PMID:37631295. |
in this review, we will focus on the role of bdnf in major depression disorder serotonergic imbalance and associated stress conditions, particularly hypothalamic-pituitary-adrenal (hpa) axis dysregulation and oxidative stress. |
2023-08-26 |
2023-09-07 |
human |
| Nazanin Hatami Bavarsad, Shokufeh Bagheri, Masoumeh Kourosh-Arami, Alireza Komak. Aromatherapy for the brain: Lavender's healing effect on epilepsy, depression, anxiety, migraine, and Alzheimer's disease: A review article. Heliyon. vol 9. issue 8. 2023-08-09. PMID:37554839. |
it improves depression by regulating glutamate receptors and inhibiting calcium channels and serotonergic factors, such as sert. |
2023-08-09 |
2023-08-16 |
Not clear |
| Shohei Noguchi, Ryo Miyaoka, Hiroshi Miyach. Clinical Images:Symmetrical Gyriform Restricted Diffusion in Severe Reversible Cerebral Vasoconstriction Syndrome. World neurosurgery. 2023-06-21. PMID:37343669. |
a 45-year-old woman with chronic depression and currently receiving dual serotonergic therapy was transferred to our department with sudden dysbasia; she also reported an antecedent thunderclap headache. |
2023-06-21 |
2023-08-14 |
Not clear |
| Jianwen Lin, Wenxin Liu, Jing Guan, Jianing Cui, Ruolin Shi, Lu Wang, Dong Chen, Yi Li. Latest updates on the serotonergic system in depression and anxiety. Frontiers in synaptic neuroscience. vol 15. 2023-05-25. PMID:37228487. |
latest updates on the serotonergic system in depression and anxiety. |
2023-05-25 |
2023-08-14 |
Not clear |
| Jianwen Lin, Wenxin Liu, Jing Guan, Jianing Cui, Ruolin Shi, Lu Wang, Dong Chen, Yi Li. Latest updates on the serotonergic system in depression and anxiety. Frontiers in synaptic neuroscience. vol 15. 2023-05-25. PMID:37228487. |
in this review, we summarize recent advances in brain localization, pathology, and therapeutic mechanisms of the serotonergic system in depression and anxiety. |
2023-05-25 |
2023-08-14 |
Not clear |
| Arzoo Pannu, Ramesh K Goya. Serotonin and Depression: Scrutiny of New Targets for Future Anti-Depressant Drug Development. Current drug targets. 2023-05-12. PMID:37170981. |
the old and new theories of possible cellular mechanisms found to be involved in the pathophysiology of major depression or stress, such as polymorphism of serotonin transporters, enzyme modulating serotonergic activity, reduction in the level of serotonin and involvement of different sub-types of receptors, have been discussed in the respective review. |
2023-05-12 |
2023-08-14 |
Not clear |
| Manish Dama, Michelle Wu, Vanessa K Tassone, Ilya Demchenko, Benicio N Frey, Roumen V Milev, Arun V Ravindran, Sagar V Parikh, Susan Rotzinger, Wendy Lou, Raymond W Lam, Sidney H Kennedy, Venkat Bha. The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 report. Psychiatry research. vol 325. 2023-05-10. PMID:37163883. |
monitoring subjective sleep-onset and mid-nocturnal insomnia during the course of treatment with serotonergic antidepressants may be useful for predicting acute remission of depression. |
2023-05-10 |
2023-08-14 |
Not clear |
| Patrick J Ronan, Wayne J Korzan, Philip L Johnson, Christopher A Lowry, Kenneth J Renner, Cliff H Summer. Prior stress and vasopressin promote corticotropin-releasing factor inhibition of serotonin release in the central nucleus of the amygdala. Frontiers in behavioral neuroscience. vol 17. 2023-04-17. PMID:37064300. |
previous work has linked crf hypersecretion, binding site changes, and dysfunctional serotonergic transmission with anxiety and affective disorders, including clinical depression. |
2023-04-17 |
2023-08-14 |
Not clear |